INSYS Therapeutics to Present at Janney Healthcare Conference

PHOENIX, Sept. 14, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, announced today that Saeed Motahari, president and chief executive officer, will present at the upcoming Janney Montgomery Scott 2018 Healthcare Conference as follows:

The presentation will be webcast live at the aforementioned time, and archived for 90 days thereafter, via the Investors section of company’s website at https://www.insysrx.com/, under Presentations & Events. Accessible at the same webpage, the presentation slides will be available during and after the conference.

About INSYS

INSYS Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve patients’ quality of life. Using proprietary spray technology and capabilities to develop pharmaceutical cannabinoids, INSYS is developing a pipeline of products intended to address unmet medical needs and the clinical shortcomings of existing commercial products. INSYS is committed to developing medications for potentially treating anaphylaxis, epilepsy, Prader-Willi syndrome, opioid addiction and overdose, and other disease areas with a significant unmet need. 

You May Also Be Interested In

• INK Communications Co. Named to Fast Company's 2026 Best Workplaces for Innovators List
• ASSYSTEM: Postponement of the publication of the 2026 half-year results
• Capgemini launches its thirteenth Employee Share Ownership Plan